Improving health is one of the toughest challenges facing the world today. As a global, innovation-driven biopharmaceutical company, AstraZeneca has a key contribution to make through the discovery, development, manufacturing and commercialisation of medicines for six important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory and inflammation.
EMM is a cluster containing around 20 countries; the majority of which are in the early life cycle stage when compared to other MENA countries in term of capabilities, brand evolution and market readiness. Therefore, In EMM; our goal is to create sustainable value for patients and customers by being one of the best-performing biopharmaceutical companies within the region.
We invest in growth opportunities, including brands such as Crestor and Symbicort – just launched 2 years ago - In addition, we pursue well defined strategy to pave the way for our diabetes fortfolio and Brilinta.
EMM is full of diversified opportunities; having said that and due to the underdeveloped nature of our countries; daily challenges are the norm here. That’s why, talented, motivated and capable people are critical to the successful achievement of our strategic ambitions.
What makes working at EMM office so great?
Our people are our greatest asset....we do our best to create harmony between the different employees and having an open environment with different means of communication which helps creates happier workers and more productive businesses.
The first step to a successful organization is to recognize that we must create an environment in which employees feel inspired and confident that they can be at their best.
|Trade name||Generic name||Formulation|
|ACCOLATE ®||Zafirlukast.||Tablets containing 20 mg|
|Arimidex||Anastrozole||Tablet contains 1 mg|
|Atacand||Candesartan Cilexetil||Tablets 4 mg, 8 mg, 16 mg and 32 mg|
|ATACAND ® PLUS||Candesartan Cilexetil And Hydrochlorothiazide||16 mg
candesartan cilexetil and 12.5 mg hydrochlorothiazide
|Betaloc ZOK||Metoprolol Succinate||Tablets 50mg, 100mg and
|Bricanyl 0.25 mg/dose||Terbutaline Sulphate||Pressurised metered dose inhaler (pMDI), Each delivered dose contains:
Terbutaline sulphate 0.25 mg
|Bricanyl Turbuhaler 0.5 mg/dose||Terbutaline Sulphate||Turbuhaler, Terbutaline sulphate 0.5 mg.|
|CASODEX ® 50 mg||Bicalutamide (Inn||Tablets 50 mg|
|CASODEX ® 150 mg||Bicalutamide (Inn||Tablets 150 mg|
|CRESTOR®||Rosuvastatin||Tablets 5 mg, 10 mg, 20 mg, 40 mg|
|DIPRIVAN||Propofol||Propofol 10 mg/ml, 20 mg/ml (2%|
|EMLA ®||Lidocaine, Prilocaine||1 g of Emla Cream contains lidocaine
25 mg, prilocaine 25 mg.
|INDERAL ®||Propranolol Hydrochloride||10 mg, 40 mg or 80 mg Propranolol Hydrochloride|
|Iressa||Gefitinib||Tablets 250 mg|
|Losec®||Omeprazole||Tablets 20 mg,|
|MARCAINE ® 0.5% SPINAL HEAVY||Bupivacaine Hydrochloride||solution for injection: 1 ml contains:
bupivacaine hydrochloride 5.0 mg.
|MERONEM ®||Meropenem||500 mg, 1 g|
|NAROPIN ®||Ropivacaine Hydrochloride||2 mg/ml, 7.5 mg/ml and 10 mg/ml|
|Nexium||Esomeprazole||Tablets 20 mg and 40 mg|
|NEXIUM 40 mg||Esomeprazole||40 mg Powder for solution for injection/infusion|
|NOLVADEX/ NOLVADEX-D ®||Tamoxifen Citrate||Nolvadex is available as tablets containing
Tamoxifen Citrate Ph. Eur equivalent to 10
mg of tamoxifen.
Nolvadex-D is available as tablets containing
Tamoxifen Citrate Ph. Eur equivalent to
20 mg of tamoxifen.
|OXIS TURBUHALER ®||Formoterol Fumarate Dihydrate||4.5 μg/dose and
|PLENDIL ®||Felodipine Tablets||5 mg and 10 mg|
|PULMICORT®, (pMDI)||Budesonide||100, 200 and 400 μg/dose|
|Rhinocort Aqua||Budesonide||32 and 64 μg/dose|
|Seroquel||Quetiapine Fumarate||25,100, 200, 300 mg Tablets|
|Symbicort Turbuhaler||Budesonide/Formoterol||80/4.5 μg/dose|
|Symbicort Turbuhaler||Budesonide/Formoterol||160/4.5 μg/dose|
|Symbicort Turbuhaler 320/9 μg/dose||320/9 μg/dose|
|TENORETIC||100 Mg Of Atenolol, And 25 Mg Chlorthalidone .||Tablets of 100 mg of Atenolol, and 25 mg Chlorthalidone .|
|TENORMIN ®||Atenolol||Tablets 50,100 mg|
|XYLOCAINE ® PUMP, SPRAY 10%||Lidocaine
|1 dose Xylocaine pump spray contains: Lidocaine base 10 mg|
|XYLOPROCT® 20 mg||Lidocaine, Hydrocortisone||1 g Xyloproct ointment contains:
Lidocaine base 50 mg, Hydrocortisone acetate 2.5 mg
1 Xyloproct suppository contains: Lidocaine base 60 mg, Hydrocortisone acetate 5 mg
|ZESTORETIC||Lisinopril Dihydrate Hydrochlorothiazide||Each tablet contains lisinopril dihydrate (equivalent to 20 mg anhydrous lisinopril) and 12.5 mg hydrochlorothiazide|
|ZESTRIL||Lisinopril Dihydrate||5 mg, 10 mg and 20 mg|
|ZOLADEX® 3.6 mg||(Goserelin)||Zoladex’ is presented as a sterile, white to
cream coloured cylindrical depot in which
goserelin acetate (equivalent to 3.6 mg of
|ZOLADEX® 3.6/10.8 mg||(Goserelin)||Zoladex is presented as a sterile, white
to cream coloured cylindrical depot in which
goserelin acetate (equivalent to 10.8 mg of
|Zomig 2.5mg||Zolmitriptan||Tablets 2.5mg|
Adverse event reporting
14C Ahmed Kamel Street
Tel: +20 (2)25170661
Fax: +20 (2)25170664